Giuliani Overview

  • Founded
  • 1889
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1
  • Investments
  • 3

Giuliani General Information

Description

Provider of pharmaceutical services in Milan, Italy. The company's services offer selection of ingredients and application of patented pharmaceutical technologies and methods to create drugs, medical devices, food supplements and cosmetics for the treatment of nutritional and gastrointestinal disorders and the care of skin, nails and hair problems.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Parent Company
Sanofi Synthelabo France
Primary Office
  • Via Pelagio Palagi
  • 20129 Milan
  • Italy
+39 800 000 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Giuliani Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Giuliani‘s full profile, request access.

Request a free trial

Giuliani Executive Team (2)

Name Title Board Seat Contact Info
Mario Giuliani Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Giuliani Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 02-Apr-2021 000000000000000000 Distributors/Wholesale 000000000 00000000
000000 27-Jun-2018 00000 00000 00 000.00 Biotechnology 000000000 00000000
MIKA Pharma 25-Mar-2010 Merger/Acquisition Drug Discovery
To view Giuliani’s complete investments and acquisitions history, request access »

Giuliani Subsidiaries (2)

Company Name Industry Location Founded
Nathura Distributors/Wholesale Montecchio Emilia, Italy 2017
0000 000000 Drug Discovery Ludwigshafen, Germany 0000
To view Giuliani’s complete subsidiaries history, request access »